These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 15198520

  • 1. Pharmacokinetics of paclitaxel-containing liposomes in rats.
    Fetterly GJ, Straubinger RM.
    AAPS PharmSci; 2003 Nov 21; 5(4):E32. PubMed ID: 15198520
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion.
    Liu X, Sun J, Chen X, Wang S, Scott H, Zhang X, Zhang Q.
    J Pharm Pharmacol; 2012 Jun 21; 64(6):775-82. PubMed ID: 22571255
    [Abstract] [Full Text] [Related]

  • 3. Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics.
    Nornoo AO, Chow DS.
    Int J Pharm; 2008 Feb 12; 349(1-2):117-23. PubMed ID: 17869458
    [Abstract] [Full Text] [Related]

  • 4. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
    Bulitta JB, Zhao P, Arnold RD, Kessler DR, Daifuku R, Pratt J, Luciano G, Hanauske AR, Gelderblom H, Awada A, Jusko WJ.
    Cancer Chemother Pharmacol; 2009 May 12; 63(6):1049-63. PubMed ID: 18791718
    [Abstract] [Full Text] [Related]

  • 5. [Comparative study on pharmacokinetics and tissue distribution of a novel microemulsion based on the paclitaxel/L-OH lipid complex and paclitaxel injection in cremophor].
    Ma YL, Ye J, Zhang PX, Xia XJ, Liu YL.
    Yao Xue Xue Bao; 2013 Nov 12; 48(11):1698-704. PubMed ID: 24475708
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.
    Gill KK, Nazzal S, Kaddoumi A.
    Eur J Pharm Biopharm; 2011 Oct 12; 79(2):276-84. PubMed ID: 21575719
    [Abstract] [Full Text] [Related]

  • 7. Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).
    Sparreboom A, Scripture CD, Trieu V, Williams PJ, De T, Yang A, Beals B, Figg WD, Hawkins M, Desai N.
    Clin Cancer Res; 2005 Jun 01; 11(11):4136-43. PubMed ID: 15930349
    [Abstract] [Full Text] [Related]

  • 8. Thermoreversible liposomal poloxamer gel for the delivery of paclitaxel: dose proportionality and hematological toxicity studies.
    Dhanikula RS, Dhanikula AB, Panchagnula R.
    Pharmazie; 2008 Jun 01; 63(6):439-45. PubMed ID: 18604987
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H.
    Biomaterials; 2008 Mar 01; 29(9):1233-41. PubMed ID: 18093646
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles.
    Dhanikula AB, Singh DR, Panchagnula R.
    Curr Drug Deliv; 2005 Jan 01; 2(1):35-44. PubMed ID: 16305406
    [Abstract] [Full Text] [Related]

  • 12. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model.
    Marchettini P, Stuart OA, Mohamed F, Yoo D, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2002 Jun 01; 49(6):499-503. PubMed ID: 12107555
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of nanoparticulate paclitaxel delivery system pharmacokinetics and model prediction of associated neutropenia.
    Ait-Oudhia S, Straubinger RM, Mager DE.
    Pharm Res; 2012 Oct 01; 29(10):2833-44. PubMed ID: 22588463
    [Abstract] [Full Text] [Related]

  • 14. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.
    Wang X, Deng L, Chen X, Pei H, Cai L, Zhao X, Wei Y, Chen L.
    J Pharm Sci; 2011 Mar 01; 100(3):1196-205. PubMed ID: 20860011
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration.
    Li R, Eun JS, Lee MK.
    Arch Pharm Res; 2011 Feb 01; 34(2):331-7. PubMed ID: 21380818
    [Abstract] [Full Text] [Related]

  • 16. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.
    Sparreboom A, van Tellingen O, Nooijen WJ, Beijnen JH.
    Cancer Res; 1996 May 01; 56(9):2112-5. PubMed ID: 8616858
    [Abstract] [Full Text] [Related]

  • 17. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
    Nornoo AO, Osborne DW, Chow DS.
    Int J Pharm; 2008 Feb 12; 349(1-2):108-16. PubMed ID: 17869459
    [Abstract] [Full Text] [Related]

  • 18. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
    Liu J, Kraut EH, Balcerzak S, Grever M, D'Ambrosio S, Chan KK.
    Cancer Chemother Pharmacol; 2002 Dec 12; 50(6):445-53. PubMed ID: 12451470
    [Abstract] [Full Text] [Related]

  • 19. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.
    Li X, Choi JS.
    Int J Pharm; 2007 Jun 07; 337(1-2):188-93. PubMed ID: 17267149
    [Abstract] [Full Text] [Related]

  • 20. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
    Jain S, Kumar D, Swarnakar NK, Thanki K.
    Biomaterials; 2012 Oct 07; 33(28):6758-68. PubMed ID: 22748771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.